Ferguson Shapiro’s iShares Biotechnology ETF IBB Stock Holding History

Ferguson Shapiro’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,966	Closed	-$981K	–	32
2020 Q2	$981K	Buy	+6,966	New	+$888K	0.68%	17

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ferguson Shapiro's IBB Position: Q3 2020 in Review

Ferguson Shapiro sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 6,966 shares — an estimated $981K sold.

Ferguson Shapiro first reported a position in IBB in Q2 2020 and held it in 1 quarter. The position peaked at $981K in Q2 2020. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Ferguson Shapiro reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
Ferguson Shapiro sold 6,966 iShares Biotechnology ETF shares in Q3 2020, an estimated $981K.
Ferguson Shapiro first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 1 quarter.
Ferguson Shapiro's iShares Biotechnology ETF position peaked at $981K in Q2 2020.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Ferguson Shapiro's 13F filing for Q3 2020, filed 12 Nov 2020.